Between 4,000 to 6,000 people are diagnosed with the cancer each year in the US, according to the American Cancer Society. GSK’s acquisition of IDRx will include IDRX-42 which is currently being ...

GSK announced on Tuesday that its investigational antibody-drug conjugate GSK'227 has been granted breakthrough therapy designation by the US Food and Drug Administration (FDA) for treating relapsed ...

Earlier this week, the American Cancer Society released the full list of 245 new and renewed research grants that were ...

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

GSK isn't revealing the size of the OS improvement yet – it has promised to do so at the American Society for Haematology ... At this year's ASCO cancer congress in February, earlier results ...

The aging population and lifestyle-related factors contribute to a surge in pancreatic cancer cases. The aggressive nature of the disease and its high mortality rate demand innovative therapies.

Today, the American Cancer Society (ACS) released Cancer Statistics, 2025, the organization's annual report on cancer facts ...

Pancreatic cancer remains a formidable foe, with the American Cancer Society estimating over 66,000 ... ONCY) (TSX: ONC), GSK plc (NYSE: GSK), AstraZeneca PLC (NASDAQ: AZN), Gilead Sciences ...